Literature DB >> 26508335

Frequency-Dependent Corticostriatal Disinhibition Resulting from Chronic Dopamine Depletion: Role of Local Striatal cGMP and GABA-AR Signaling.

Vatsala R Jayasinghe1, Eden Flores-Barrera1, Anthony R West2, Kuei Y Tseng1.   

Abstract

The onset of motor deficits in parkinsonism is thought to result from dopamine (DA) loss-induced corticostriatal disruption and the development of excessive cortico-basal ganglia synchronization. To gain insights into the mechanisms underlying such corticostriatal dysfunction, we conducted local field potential (LFP) recordings in rats and measured how striatal manipulations of DA, cyclic guanosine monophosphate (cGMP), and gamma-aminobutyric acid- A receptor (GABA-AR) signaling impact corticostriatal transmission at specific oscillatory frequencies. Results indicate that the degree of 6-hydroxydopamine-induced DA lesion and subsequent changes in striatal DA, cGMP, and GABA-AR signaling contribute to impair LFP suppression such that the DA-depleted striatum becomes more permissive to cortically driven oscillations at 10-20 Hz, and to a lesser extent, at 40 Hz. Notably, the corticostriatal dysfunction at 40 Hz emerged only when the degree of chronic DA lesion surpassed 90%, which coincides with the appearance of severe forelimb stepping deficits. Collectively, these results indicate that several mechanisms contribute to suppress LFP within the 10-20 Hz range, yet a critical level of striatal GABAergic activity is required for sustaining corticostriatal inhibition at 40 Hz. Both the degree and chronicity of DA lesion are major contributing factors to the severity of motor and striatal GABAergic deficits that could only be reversed by strengthening local GABA-AR function.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  basal ganglia; electrophysiology; local field potentials; oscillations; parkinsonism; plasticity

Mesh:

Substances:

Year:  2017        PMID: 26508335      PMCID: PMC5939220          DOI: 10.1093/cercor/bhv241

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  39 in total

1.  Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.

Authors:  Kuei Y Tseng; Lucila Kargieman; Sebastian Gacio; Luis A Riquelme; M Gustavo Murer
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

Review 2.  Oscillations in the basal ganglia under normal conditions and in movement disorders.

Authors:  Plamen Gatev; Olivier Darbin; Thomas Wichmann
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

3.  Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions.

Authors:  K Y Tseng; F Kasanetz; L Kargieman; L A Riquelme; M G Murer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 4.  The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

Authors:  R K Schwarting; J P Huston
Journal:  Prog Neurobiol       Date:  1996-10       Impact factor: 11.685

5.  Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.

Authors:  S Y Ma; M Röyttä; J O Rinne; Y Collan; U K Rinne
Journal:  J Neurol Sci       Date:  1997-10-03       Impact factor: 3.181

6.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.

Authors:  M Olsson; G Nikkhah; C Bentlage; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

7.  Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

Authors:  Irene Avila; Louise C Parr-Brownlie; Elena Brazhnik; Edward Castañeda; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-12-04       Impact factor: 5.330

8.  Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.

Authors:  Malgorzata Chalimoniuk; Józef Langfort; Nadezda Lukacova; Józef Marsala
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

9.  Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses.

Authors:  Yiyue Zhang; Gloria E Meredith; Nasya Mendoza-Elias; David J Rademacher; Kuei Y Tseng; Kathy Steece-Collier
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

10.  Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease?

Authors:  Anthony R West; Kuei Y Tseng
Journal:  Front Syst Neurosci       Date:  2011-06-30
View more
  5 in total

1.  Prolonged withdrawal from cocaine self-administration affects prefrontal cortex- and basolateral amygdala-nucleus accumbens core circuits but not accumbens GABAergic local interneurons.

Authors:  Anthony Purgianto; Michael E Weinfeld; Marina E Wolf
Journal:  Addict Biol       Date:  2016-07-25       Impact factor: 4.280

2.  Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram.

Authors:  Shreaya Chakroborty; Thomas R Geisbush; Elena Dale; Alan L Pehrson; Connie Sánchez; Anthony R West
Journal:  Front Pharmacol       Date:  2017-10-26       Impact factor: 5.810

3.  Dopaminergic Modulation of Forced Running Performance in Adolescent Rats: Role of Striatal D1 and Extra-striatal D2 Dopamine Receptors.

Authors:  Angel Toval; Daniel Garrigos; Yevheniy Kutsenko; Miroljub Popović; Bruno Ribeiro Do-Couto; Nicanor Morales-Delgado; Kuei Y Tseng; José Luis Ferran
Journal:  Mol Neurobiol       Date:  2021-01-04       Impact factor: 5.590

4.  Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia.

Authors:  Rayanne Poletti Guimarães; Danilo Leandro Ribeiro; Keila Bariotto Dos Santos; Carlos Henrique Zanello Talarico; Lívea Dornela Godoy; Fernando E Padovan-Neto
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30

5.  The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease.

Authors:  Feras Altwal; Connor Moon; Anthony R West; Heinz Steiner
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.